From Fragmented to Focused: Claritas Rx Omnichannel CRM Drives 95% Outreach Success for Delayed Authorizations Across Oncology and Neurology Brands

A mid-sized U.S. pharmaceutical company supporting oncology and neurology brands faced significant barriers in managing field reimbursement activities across its portfolio. FRMs struggled with disparate systems that prevented effective case prioritization, while leadership lacked unified visibility into team productivity and patient access support outcomes.

• Enabling FRMs to effectively prioritize cases and track key account interactions across multiple brands.
• Monitoring pending authorizations and managing provider outreach without a centralized platform.
• Providing leadership with actionable insight into team productivity and engagement across brand portfolios.

• 95% outreach rate achieved for delayed authorizations: For healthcare provider accounts with authorizations pending over 20 days, FRMs achieved a 95% outreach rate within just five business days using automated follow-ups and detailed case logging.
• Unified case visibility across 10 FRMs and multiple brands: The omnichannel CRM enabled high-priority case tracking across oncology and neurology portfolios, significantly enhancing response speed and coordination.
• Real-time leadership reporting and productivity metrics: Robust activity management reporting provided leadership with clear visibility into team performance, enabling more efficient resource allocation and improved patient support outcomes.

Through this strategic CRM implementation, the company transformed its case management workflow, strengthening partner relationships and boosting coordination between all parties involved in patient access support.

Source: Claritas Rx, data on file, 2023. Based on a mid-sized pharmaceutical company’s oncology and neurology brands.